[1]
|
R. D. Brasfield and T. K. das von Gupta, “Recklinghausen’s Disease: A Clinicopathological Study,” Annals of Surgery, Vol. 175, No. 1, 1972, pp. 86-104.
doi:10.1097/00000658-197201000-00015
|
[2]
|
M. Lammert, J. M. Friedman, L. Kluwe and V. F. Mautner, “Prevalence of Neurofibromatosis 1 in German Children at Elementary School Enrollment,” Archives of Dermatology, Vol. 141, No. 1, 2005, pp. 71-74.
doi:10.1001/archderm.141.1.71
|
[3]
|
L. Valeyrie-Allanore, N. Ismaili, S. Bastuji-Garin, J. Zeller, J. Wechsler, J. Revuz and P. Wolkenstein, “Symptoms Associated with Malignancy of Peripheral Nerve Sheath Tumours: A Retrospective Study of 69 Patients with Neurofibromatosis 1,” British Journal of Dermatology, Vol. 153, No. 1, 2005, pp. 79-82.
doi:10.1111/j.1365-2133.2005.06558.x
|
[4]
|
M. M. Feldkamp, D. H. Gutmann and A. Guha, “Neurofibromatosis Type 1: Piecing the Puzzle Together,” Canadian Journal of Neurological Sciences, Vol. 25, No. 3, 1998, pp. 181-191.
|
[5]
|
J. M. McGaughran, D. I. Harris, D. Donnai, D. Teare, R. MacLeoa, R. Westerbeek, H. Kingston, M. Super, R. Harris and D. Q. Evans, “A Clinical Study of Type 1 Neurofibromatosis in North West England,” Journal of Medical Genetics, Vol. 36, No. 3, 1999, pp. 197-203.
|
[6]
|
S. A. Rasmussen, Q. Yang and J. M. Friedman, “Mortality in Neurofibromatosis 1: An Analysis Using U.S. Death Certificates,” The American Journal of Human Genetics, Vol. 68, No. 5, 2001, pp. 1110-1111. doi:10.1086/320121
|
[7]
|
M. Zoller, B. Rembeck, H. O. Akesson and L. Angervall, “Life Expectancy, Mortality and Prognostic Factors in Neurofibromatosis Type 1: A Twelve-Year Follow-Up of an Epidemiological Study in Goteborg, Sweden,” Acta Dermato-Venereologica, Vol. 75, No. 2, 1995, pp. 136-140.
|
[8]
|
R. A. Lewis, L. P. Gerson, K. A. Axelson, V. M. Riccardi and R. P. von Whitford, “Recklinghausen Neurofibromatosis. II: Incidence of Optic Gliomata,” Ophthalmology, Vol. 91, No. 8, 1984, pp. 929-935.
|
[9]
|
A. Creange, J. Zeller, S. Rostaing-Rigattieri, P. Brugières, J. D. Degos, J. Revuz and P. Wolkenstein, “Neurological Complications of Neurofibromatosis Type 1 in Adulthood,” Brain, Vol. 122, No. 3, 1999; pp. 473-481.
doi:10.1093/brain/122.3.473
|
[10]
|
J. S. Guillamo, A. Creange, C. Kalifa, J. Grill, D. Rodriquez, F. Doz, S. Barbarot, M. Zerah, M. Sanson, S. Bastuji-Garia and P. Wolkenstein, “Prognostic Factors of CNS Tumours in Neurofibromatosis 1 (NF1): A Retrospective Study of 104 Patients,” Brain, Vol. 126, No. 1, 2003, pp. 152-160.
|
[11]
|
A. R. Wychulis, W. S. Payne, O. T. Clagett and L. B. Wodner, “Surgical Treatment of Mediastinal Tumors: A 40-Year Experience,” The Journal of Thoracic and Cardiovascular Surgery, Vol. 62, No. 3, 1971, pp. 379-392.
|
[12]
|
B. S. Ducatman, B. W. Scheithauer, D. G. Piepgras, H. M. Reiman and D. M. Ilstrup, “Malignant Peripheral Nerve Sheath Tumors. A clinicopathologic Study of 120 Cases,” Cancer, Vol. 57, No. 10, 1986, pp. 2006-2021.
doi:10.1002/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO;2-6
|
[13]
|
R. E. Ferner and D. H. Gutmann, “International Consensus Statement on Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis,” Cancer Research, Vol. 62, No. 5, 2002, pp. 1573-1577.
|
[14]
|
J. M. Meis, F. M. Enzinger, K. L. Martz and J. A. Neal, “Malignant Peripheral Nerve Sheath Tumors (Malignant Schwannomas) in Children,” The American Journal of Surgical Pathology, Vol. 16, No. 7, 1992, pp. 694-707.
doi:10.1097/00000478-199207000-00008
|
[15]
|
J. S. Suh, P. Abenoza, H. R. Galloway, L. I. Everson and H. J. Griffiths, “Peripheral (Extracranial) Nerve Tumors: Correlation of MR Imaging and Histologic Findings,” Radiology, Vol. 183, No. 2, 1992, pp. 341-346.
|
[16]
|
D. G. Varma, A. Moulopoulos, A. S. Sara, N. Leeds, R. Kumar and E. E. Kim, “MR Imaging of Extracranial Nerve Sheath Tumors,” Journal of Computer Assisted Tomography, Vol. 16, No. 3, 1992, pp. 448-453.
doi:10.1097/00004728-199205000-00020
|
[17]
|
T. T. Zacharia, D. Jaramillo, T. Y. Poussaint, B. Korf, “MR Imaging of Abdominopelvic Involvement in Neurofibromatosis Type 1: A Review of 43 Patients,” Pediatric Radiology, Vol. 35, No. 3, 2005, pp. 317-322.
doi:10.1007/s00247-004-1352-z
|
[18]
|
R. J. Packer, D. H. Gutmann, A. Rubenstein, D. Viskochil, R. A. Zimmerman and G. Vezina, “Plexiform Neurofibromas in NF1: Toward Biologic-Based Therapy,” Neurology, Vol. 58, No. 10, 2002, pp. 1461-1470.
|
[19]
|
A. Ferrari, G. Bisogno, A. Macaluso, M. Casanova, P. D’Angelo, P. Pierani, I. Zanetti, R. Alaggio, G. Cecchetto and M. Carti, “Soft-Tissue Sarcomas in Children and Adolescents with Neurofibromatosis Type 1,” Cancer, Vol. 109, No. 7, 2007, pp. 1406-1412.
|
[20]
|
H. Neville, C. Corpron, M. L. Blakely and R. Andrassy, “Pediatric Neurofibrosarcoma,” Journal of Pediatric Surgery, Vol. 38, No. 3, 2003, pp. 343-346.
|